Baxion
Screening
Tags
Alerts
Theme
Avenue Therapeutics, Inc.
ATXI
·
OTC
·
$0.23
Share Price as of 11/2
·
$757,842
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/07/26
10-Q
Q1 ended 03/31/26
05/08/26
10-K
FY 2025
03/30/26
10-Q
Q3 ended 09/30/25
11/13/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
02/23/26
8-K
Current report
12/31/25
8-K
Current report
11/18/25
8-K
Current report
11/12/25
8-K
Current report
04/30/25
Prospectuses and Registrations
Filter
POS AM
Post-effective amendment
12/15/25
S-3
Shelf registration
12/04/24
S-8
Registration of securities for employees
07/12/24
424B3
Prospectus
05/10/24
424B5
Prospectus supplement
05/10/24
Proxies
Filter
DEF 14A
Definitive proxy
12/05/25
DEF 14A
Definitive proxy
05/06/24
DEFA14A
Additional proxy materials
05/06/24
DEF 14C
Definitive information statement
03/18/24
PRE 14C
PRE 14C
03/08/24
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
02/17/26
SC 13G
Beneficial ownership
02/14/25
SC 13G/A
Beneficial ownership (amended)
02/14/25
Form 4
Insider transaction
12/03/24
SC 13G
Beneficial ownership
11/14/24
Other
Filter
EFFECT
Request for effectiveness
12/16/25
RW
Registration withdrawal
12/15/25
25-NSE
Removal from listing
07/18/25
EFFECT
Request for effectiveness
05/10/24
CORRESP
Correspondence with the SEC
05/08/24
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/07/26
10-Q
Q1 ended 03/31/26
05/08/26
10-K
FY 2025
03/30/26
8-K
Current report
02/23/26
8-K
Current report
12/31/25
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
02/17/26
SC 13G
Beneficial ownership
02/14/25
SC 13G/A
Beneficial ownership (amended)
02/14/25
Form 4
Insider transaction
12/03/24
SC 13G
Beneficial ownership
11/14/24